Direxion Daily TSLA Bull 1.5X Shares

ProShares UltraShort Bloomberg Natrl Gas

GraniteShares 1.5x Long NVDA Daily ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

Bank Of Montreal

GraniteShares 1.25x Long Tesla Daily ETF

Direxion Daily S&P Biotech Bear 3X ETF

ProShares UltraShort Silver

Direxion Daily FTSE China Bull 3X ETF

VS TR 2x Long VIX Futures ETF

ProShares Ultra Bloomberg Natural Gas

T-REX 2X Inverse Tesla Daily Target ETF

Volatility Shares Trust 2x Ether ETF

MicroSectors Gold Miners 3X Leveraged ETN

Direxion Daily S&P Biotech Bull 3X ETF

ProShares Ultra Silver

United States Natural Gas

Direxion Daily Gold Miners Bull 3X ETF

ARK Genomic Revolution Multi-Sector ETF

iShares US Home Construction

Incannex Healthcare Limited American Depositary Shares

Innovative Eyewear Inc. Common Stock

Septerna Inc. Common Stock

HWH International Inc. Common Stock

DevvStream Corp. Common Stock

CoreWeave Inc. Class A Common Stock

Rigetti Computing Inc. Common Stock

Super Micro Computer Inc. Common Stock

EchoStar  Corporation Common Stock

Oklo Inc.

Inno Holdings Inc. Common Stock

Gryphon Digital Mining Inc Common Stock

Next Technology Holding Inc. Ordinary Shares

Kindly MD Inc. Common Stock

Nuvve Holding Corp. Common Stock

Oriental Rise Holdings Limited Ordinary Shares

Classover Holdings Inc. Class B Common Stock

Hyperscale Data Inc. Common Stock

MicroAlgo Inc. Ordinary Shares

AgriFORCE  Growing Systems Ltd. Common Shares

Click here to get full coverage on Is the Options Market Predicting a Spike in Supernus Pharmaceuticals (SUPN) Stock? - TradingView

Is the Options Market Predicting a Spike in Supernus Pharmaceuticals (SUPN) Stock?  TradingView

Is the Options Market Predicting a Spike in Supernus Pharmaceuticals (SUPN) Stock? - TradingView

Click here to get full coverage on Solid Earnings Reflect Supernus Pharmaceuticals' (NASDAQ:SUPN) Strength As A Business - Yahoo Finance

Solid Earnings Reflect Supernus Pharmaceuticals' (NASDAQ:SUPN) Strength As A Business  Yahoo Finance

Solid Earnings Reflect Supernus Pharmaceuticals' (NASDAQ:SUPN) Strength As A Business - Yahoo Finance

Click here to get full coverage on SUPN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Supernus Pharmaceuticals, Inc. investment - ACCESS Newswire

SUPN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Supernus Pharmaceuticals, Inc. investment  ACCESS Newswire

SUPN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Supernus Pharmaceuticals, Inc. investment - ACCESS Newswire

Click here to get full coverage on Supernus (SUPN) Reports Q1 Earnings: What Key Metrics Have to Say - MSN

Supernus (SUPN) Reports Q1 Earnings: What Key Metrics Have to Say  MSN

Supernus (SUPN) Reports Q1 Earnings: What Key Metrics Have to Say - MSN

Click here to get full coverage on SUPERNUS PHARMACEUTICALS Earnings Results: $SUPN Reports Quarterly Earnings - Nasdaq

SUPERNUS PHARMACEUTICALS Earnings Results: $SUPN Reports Quarterly Earnings  Nasdaq

SUPERNUS PHARMACEUTICALS Earnings Results: $SUPN Reports Quarterly Earnings - Nasdaq

Click here to get full coverage on Supernus: New Direction Beckons After MDD Drug Fail (Rating Downgrade) (NASDAQ:SUPN) - Seeking Alpha

Supernus: New Direction Beckons After MDD Drug Fail (Rating Downgrade) (NASDAQ:SUPN)  Seeking Alpha

Supernus: New Direction Beckons After MDD Drug Fail (Rating Downgrade) (NASDAQ:SUPN) - Seeking Alpha

Click here to get full coverage on Supernus Q1 2025 Earnings Preview: CEO Jack Khattar to Detail Financial Performance May 6 - Stock Titan

Supernus Q1 2025 Earnings Preview: CEO Jack Khattar to Detail Financial Performance May 6  Stock Titan

Supernus Q1 2025 Earnings Preview: CEO Jack Khattar to Detail Financial Performance May 6 - Stock Titan

Click here to get full coverage on Supernus Pharmaceuticals Earnings: What To Look For From SUPN - Yahoo Finance

Supernus Pharmaceuticals Earnings: What To Look For From SUPN  Yahoo Finance

Supernus Pharmaceuticals Earnings: What To Look For From SUPN - Yahoo Finance

Click here to get full coverage on What Makes Supernus (SUPN) a New Buy Stock - Nasdaq

What Makes Supernus (SUPN) a New Buy Stock  Nasdaq

What Makes Supernus (SUPN) a New Buy Stock - Nasdaq

Click here to get full coverage on Supernus Pharmaceuticals Inc (SUPN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

Supernus Pharmaceuticals Inc (SUPN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...  Yahoo Finance

Supernus Pharmaceuticals Inc (SUPN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

Click here to get full coverage on Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 Sales Beat Estimates But Full-Year Sales Guidance Misses Expectations - Yahoo Finance

Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 Sales Beat Estimates But Full-Year Sales Guidance Misses Expectations  Yahoo Finance

Supernus Pharmaceuticals’s (NASDAQ:SUPN) Q1 Sales Beat Estimates But Full-Year Sales Guidance Misses Expectations - Yahoo Finance

Click here to get full coverage on Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance

Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Surpass Estimates  Yahoo Finance

Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance

Click here to get full coverage on Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth?  Yahoo Finance

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Pharma Stock to Buy for Long Term Growth? - Yahoo Finance

Click here to get full coverage on Supernus Pharmaceuticals Inc (SUPN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

Supernus Pharmaceuticals Inc (SUPN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ...  Yahoo Finance

Supernus Pharmaceuticals Inc (SUPN) Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

Click here to get full coverage on Supernus Pharmaceuticals (SUPN): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance

Supernus Pharmaceuticals (SUPN): Buy, Sell, or Hold Post Q4 Earnings?  Yahoo Finance

Supernus Pharmaceuticals (SUPN): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance

Click here to get full coverage on Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks - Yahoo Finance

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks  Yahoo Finance

Q4 Earnings Recap: Supernus Pharmaceuticals (NASDAQ:SUPN) Tops Branded Pharmaceuticals Stocks - Yahoo Finance

Click here to get full coverage on What To Expect From Supernus Pharmaceuticals’s (SUPN) Q4 Earnings - Yahoo Finance

What To Expect From Supernus Pharmaceuticals’s (SUPN) Q4 Earnings  Yahoo Finance

What To Expect From Supernus Pharmaceuticals’s (SUPN) Q4 Earnings - Yahoo Finance

Click here to get full coverage on BREAKING: Supernus Pharmaceuticals, Inc. Shares Down 14%; Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation - GlobeNewswire

BREAKING: Supernus Pharmaceuticals, Inc. Shares Down 14%; Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation  GlobeNewswire

BREAKING: Supernus Pharmaceuticals, Inc. Shares Down 14%; Investors Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation - GlobeNewswire

Click here to get full coverage on Supernus Pharmaceuticals Inc (SUPN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - GuruFocus

Supernus Pharmaceuticals Inc (SUPN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges  GuruFocus

Supernus Pharmaceuticals Inc (SUPN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges - GuruFocus

Click here to get full coverage on Earnings Flash (SUPN) Supernus Pharmaceuticals Q1 Loss Per Share $0.21 Vs. FactSet Est. Loss $0.01 - marketscreener.com

Earnings Flash (SUPN) Supernus Pharmaceuticals Q1 Loss Per Share $0.21 Vs. FactSet Est. Loss $0.01  marketscreener.com

Earnings Flash (SUPN) Supernus Pharmaceuticals Q1 Loss Per Share $0.21 Vs. FactSet Est. Loss $0.01 - marketscreener.com

Click here to get full coverage on Supernus Pharmaceuticals (NASDAQ:SUPN) Delivers Strong Q4 Numbers - Yahoo Finance

Supernus Pharmaceuticals (NASDAQ:SUPN) Delivers Strong Q4 Numbers  Yahoo Finance

Supernus Pharmaceuticals (NASDAQ:SUPN) Delivers Strong Q4 Numbers - Yahoo Finance

Click here to get full coverage on Supernus Announces First Quarter 2025 Financial Results | SUPN Stock News - GuruFocus

Supernus Announces First Quarter 2025 Financial Results | SUPN Stock News  GuruFocus

Supernus Announces First Quarter 2025 Financial Results | SUPN Stock News - GuruFocus

Click here to get full coverage on SUPN Reports Higher than Expected Q1 Revenue at $149.8M | SUPN S - GuruFocus

SUPN Reports Higher than Expected Q1 Revenue at $149.8M | SUPN S  GuruFocus

SUPN Reports Higher than Expected Q1 Revenue at $149.8M | SUPN S - GuruFocus

Click here to get full coverage on Decoding Supernus Pharmaceuticals Inc (SUPN): A Strategic SWOT I - GuruFocus

Decoding Supernus Pharmaceuticals Inc (SUPN): A Strategic SWOT I  GuruFocus

Decoding Supernus Pharmaceuticals Inc (SUPN): A Strategic SWOT I - GuruFocus

Click here to get full coverage on Supernus Q4 Earnings: CEO and CFO Set to Unveil Full Year Performance Metrics - Stock Titan

Supernus Q4 Earnings: CEO and CFO Set to Unveil Full Year Performance Metrics  Stock Titan

Supernus Q4 Earnings: CEO and CFO Set to Unveil Full Year Performance Metrics - Stock Titan

Click here to get full coverage on SA analyst downgrades: TSLA, TXN, ORLY, SUPN, KDP (TSLA:NASDAQ) - Seeking Alpha

SA analyst downgrades: TSLA, TXN, ORLY, SUPN, KDP (TSLA:NASDAQ)  Seeking Alpha

SA analyst downgrades: TSLA, TXN, ORLY, SUPN, KDP (TSLA:NASDAQ) - Seeking Alpha

Click here to get full coverage on Supernus: Q1 Earnings Snapshot - The Washington Post

Supernus: Q1 Earnings Snapshot  The Washington Post

Supernus: Q1 Earnings Snapshot - The Washington Post

Click here to get full coverage on 3 Stocks Under $50 That Concern Us - Yahoo Finance

3 Stocks Under $50 That Concern Us  Yahoo Finance

3 Stocks Under $50 That Concern Us - Yahoo Finance

Click here to get full coverage on Historic FDA Win: New Non-Surgical Treatment Revolutionizes Parkinson's Care - Supernus Makes Breakthrough - Stock Titan

Historic FDA Win: New Non-Surgical Treatment Revolutionizes Parkinson's Care - Supernus Makes Breakthrough  Stock Titan

Historic FDA Win: New Non-Surgical Treatment Revolutionizes Parkinson's Care - Supernus Makes Breakthrough - Stock Titan

Click here to get full coverage on Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stock to Buy Now? - Yahoo Finance

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stock to Buy Now?  Yahoo Finance

Is Supernus Pharmaceuticals, Inc. (SUPN) the Best Small Cap Pharma Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on Down -20.07% in 4 Weeks, Here's Why Supernus (SUPN) Looks Ripe for a Turnaround - Yahoo Finance

Down -20.07% in 4 Weeks, Here's Why Supernus (SUPN) Looks Ripe for a Turnaround  Yahoo Finance

Down -20.07% in 4 Weeks, Here's Why Supernus (SUPN) Looks Ripe for a Turnaround - Yahoo Finance

Click here to get full coverage on Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression - GlobeNewswire

Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression  GlobeNewswire

Supernus Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression - GlobeNewswire

Click here to get full coverage on 3 of Wall Street’s Favorite Stocks with Questionable Fundamentals - The Globe and Mail

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals  The Globe and Mail

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals - The Globe and Mail

Click here to get full coverage on What Questions Should Investors Ask Supernus CEO at Upcoming TD Cowen Conference? - Stock Titan

What Questions Should Investors Ask Supernus CEO at Upcoming TD Cowen Conference?  Stock Titan

What Questions Should Investors Ask Supernus CEO at Upcoming TD Cowen Conference? - Stock Titan

Click here to get full coverage on Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025 | SUPN Stock News - GuruFocus

Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025 | SUPN Stock News  GuruFocus

Supernus Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call and Webcast on May 6, 2025 | SUPN Stock News - GuruFocus

Click here to get full coverage on (SUPN) Long Term Investment Analysis - news.stocktradersdaily.com

(SUPN) Long Term Investment Analysis  news.stocktradersdaily.com

(SUPN) Long Term Investment Analysis - news.stocktradersdaily.com

Click here to get full coverage on Supernus: New Approval Holds Promise Of Increased Growth (SUPN) - Seeking Alpha

Supernus: New Approval Holds Promise Of Increased Growth (SUPN)  Seeking Alpha

Supernus: New Approval Holds Promise Of Increased Growth (SUPN) - Seeking Alpha

Click here to get full coverage on 3 Stocks Under $50 That Concern Us - The Globe and Mail

3 Stocks Under $50 That Concern Us  The Globe and Mail

3 Stocks Under $50 That Concern Us - The Globe and Mail

Click here to get full coverage on Supernus to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Supernus to Participate in Two Upcoming Investor Conferences  GlobeNewswire

Supernus to Participate in Two Upcoming Investor Conferences - GlobeNewswire

Click here to get full coverage on Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals? - Yahoo Finance

Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals?  Yahoo Finance

Does The Market Have A Low Tolerance For Supernus Pharmaceuticals, Inc.'s (NASDAQ:SUPN) Mixed Fundamentals? - Yahoo Finance

Click here to get full coverage on SUPN STOCK ALERT: Levi & Korsinsky Notifies Supernus Pharmaceuticals, Inc. Investors of an Ongoing Investigation - Louisiana First News

SUPN STOCK ALERT: Levi & Korsinsky Notifies Supernus Pharmaceuticals, Inc. Investors of an Ongoing Investigation  Louisiana First News

SUPN STOCK ALERT: Levi & Korsinsky Notifies Supernus Pharmaceuticals, Inc. Investors of an Ongoing Investigation - Louisiana First News

Click here to get full coverage on Supernus Announces First Quarter 2025 Financial Results - The Globe and Mail

Supernus Announces First Quarter 2025 Financial Results  The Globe and Mail

Supernus Announces First Quarter 2025 Financial Results - The Globe and Mail

Click here to get full coverage on Press Release Distribution & PR Platform - ACCESS Newswire

Press Release Distribution & PR Platform  ACCESS Newswire

Press Release Distribution & PR Platform - ACCESS Newswire

Click here to get full coverage on Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates - MSN

Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates  MSN

Supernus Pharmaceuticals (SUPN) Beats Q4 Earnings and Revenue Estimates - MSN

Click here to get full coverage on Supernus Pharmaceuticals Full Year 2024 Earnings: Beats Expectations - simplywall.st

Supernus Pharmaceuticals Full Year 2024 Earnings: Beats Expectations  simplywall.st

Supernus Pharmaceuticals Full Year 2024 Earnings: Beats Expectations - simplywall.st

Click here to get full coverage on Several Supernus Pharmaceuticals Insiders Sell Shares Sending Potential Negative Signal - simplywall.st

Several Supernus Pharmaceuticals Insiders Sell Shares Sending Potential Negative Signal  simplywall.st

Several Supernus Pharmaceuticals Insiders Sell Shares Sending Potential Negative Signal - simplywall.st

Click here to get full coverage on 3 Healthcare Stocks with Mounting Challenges - The Globe and Mail

3 Healthcare Stocks with Mounting Challenges  The Globe and Mail

3 Healthcare Stocks with Mounting Challenges - The Globe and Mail

Click here to get full coverage on Supernus Pharmaceuticals CMO sells shares worth $36,292 - Investing.com

Supernus Pharmaceuticals CMO sells shares worth $36,292  Investing.com

Supernus Pharmaceuticals CMO sells shares worth $36,292 - Investing.com

Click here to get full coverage on Supernus Pharmaceuticals exec sells shares worth $376,236 - Investing.com

Supernus Pharmaceuticals exec sells shares worth $376,236  Investing.com

Supernus Pharmaceuticals exec sells shares worth $376,236 - Investing.com

Click here to get full coverage on Cantor Fitzgerald cuts Supernus stock rating, target to $36 - Investing.com

Cantor Fitzgerald cuts Supernus stock rating, target to $36  Investing.com

Cantor Fitzgerald cuts Supernus stock rating, target to $36 - Investing.com

Click here to get full coverage on Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Call Transcript - Insider Monkey

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Call Transcript  Insider Monkey

Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Q4 2024 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on 10 Best Pharma Stocks to Buy for Long Term Growth - Insider Monkey

10 Best Pharma Stocks to Buy for Long Term Growth  Insider Monkey

10 Best Pharma Stocks to Buy for Long Term Growth - Insider Monkey

Click here to get full coverage on Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks - The Globe and Mail

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks  The Globe and Mail

Unpacking Q4 Earnings: Pfizer (NYSE:PFE) In The Context Of Other Branded Pharmaceuticals Stocks - The Globe and Mail

Click here to get full coverage on Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks - The Globe and Mail

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks  The Globe and Mail

SUPN

Price Chart

Key Statistics

Technicals

About SUPN

Latest News

Is the Options Market Predicting a Spike in Supernus Pharmaceuticals (SUPN) Stock? - TradingView

Solid Earnings Reflect Supernus Pharmaceuticals' (NASDAQ:SUPN) Strength As A Business - Yahoo Finance

SUPN ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Supernus Pharmaceuticals, Inc. investment - ACCESS Newswire

Advanced Charts

Top Gainers

Top Losers